Xiubin Gu

2.3k total citations · 1 hit paper
13 papers, 1.9k citations indexed

About

Xiubin Gu is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Xiubin Gu has authored 13 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Xiubin Gu's work include Barrier Structure and Function Studies (3 papers), Fibroblast Growth Factor Research (2 papers) and Melanoma and MAPK Pathways (2 papers). Xiubin Gu is often cited by papers focused on Barrier Structure and Function Studies (3 papers), Fibroblast Growth Factor Research (2 papers) and Melanoma and MAPK Pathways (2 papers). Xiubin Gu collaborates with scholars based in United States, China and Israel. Xiubin Gu's co-authors include Hans-Christian Reinecker, Beth A. McCormick, Stephan Brand, Jan Hendrik Niess, Jatin M. Vyas, James G. Fox, Dan R. Littman, Hidde L. Ploegh, Steffen Jung and Marianne Boes and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Xiubin Gu

12 papers receiving 1.8k citations

Hit Papers

CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal... 2005 2026 2012 2019 2005 400 800 1.2k

Peers

Xiubin Gu
Dominique Gatto Australia
Ulf Yrlid Sweden
Amlan Biswas United States
Sky W. Brubaker United States
Dominique Gatto Australia
Xiubin Gu
Citations per year, relative to Xiubin Gu Xiubin Gu (= 1×) peers Dominique Gatto

Countries citing papers authored by Xiubin Gu

Since Specialization
Citations

This map shows the geographic impact of Xiubin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiubin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiubin Gu more than expected).

Fields of papers citing papers by Xiubin Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiubin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiubin Gu. The network helps show where Xiubin Gu may publish in the future.

Co-authorship network of co-authors of Xiubin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiubin Gu. A scholar is included among the top collaborators of Xiubin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiubin Gu. Xiubin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Xi, Simon, Patricia Soulard, Kai Li, et al.. (2024). Effect of RGT-61159 on inhibition of oncogene c-MYB synthesis and tumor growth inhibition in a broad range of ACC PDX models, at well tolerated doses in rodents and non-human primates.. Journal of Clinical Oncology. 42(16_suppl). 6107–6107. 4 indexed citations
2.
3.
Dransfield, Daniel T., Jennifer Lee, Carol Waghorne, et al.. (2013). Abstract A278: ARQ 087, a multi-tyrosine kinase inhibitor with potent in vitro and in vivo activity in FGFR2 driven models.. Molecular Cancer Therapeutics. 12(11_Supplement). A278–A278. 4 indexed citations
4.
Yu, Yi, Xiubin Gu, Xiaolan Zhao, et al.. (2011). Abstract 3571: Exploratory biomarker discovery for clinical development of ARQ 087, a potent pan-FGFR kinase inhibitor. Cancer Research. 71(8_Supplement). 3571–3571. 1 indexed citations
5.
Zhao, Xiaolan, Xiubin Gu, Edward Chang, et al.. (2010). Abstract 2517: Pharmacodynamic biomarkers for ARQ 736, a small molecule BRAF inhibitor. Cancer Research. 70(8_Supplement). 2517–2517. 5 indexed citations
6.
Cousens, Laura A., Carol Waghorne, Scott J. Rodig, et al.. (2009). Abstract B117: Expression of c-MET and related oncogenic signals in formalin-fixed paraffin-embedded human tumors. Molecular Cancer Therapeutics. 8(12_Supplement). B117–B117. 1 indexed citations
7.
Zhang, Bin, et al.. (2008). High-Content Fluorescent-Based Assay for Screening Activators of DNA Damage Checkpoint Pathways. SLAS DISCOVERY. 13(6). 538–543. 11 indexed citations
8.
Niess, Jan Hendrik, David J. Zammit, Rajesh Ravindran, et al.. (2006). CCR6-Mediated Dendritic Cell Activation of Pathogen-Specific T Cells in Peyer's Patches. Immunity. 24(5). 623–632. 194 indexed citations
9.
Niess, Jan Hendrik, Stephan Brand, Xiubin Gu, et al.. (2005). CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance. Science. 307(5707). 254–258. 1232 indexed citations breakdown →
10.
Brand, Stephan, Takanori Sakaguchi, Xiubin Gu, Sean P. Colgan, & Hans‐Christian Reinecker. (2002). Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology. 122(1). 166–177. 86 indexed citations
11.
Sakaguchi, Takanori, Henrik Köhler, Xiubin Gu, Beth A. McCormick, & Hans-Christian Reinecker. (2002). Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cellular Microbiology. 4(6). 367–381. 113 indexed citations
13.
Nishiyama, Raisuke, Takanori Sakaguchi, Tetsushi Kinugasa, et al.. (2001). Interleukin-2 Receptor β Subunit-dependent and -independent Regulation of Intestinal Epithelial Tight Junctions. Journal of Biological Chemistry. 276(38). 35571–35580. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026